Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 15, Number 1—January 2009

Sphingomonas paucimobilis Bloodstream Infections Associated with Contaminated Intravenous Fentanyl1

Lisa L. MaragakisComments to Author , Romanee Chaiwarith, Arjun Srinivasan, Francesca J. Torriani, Edina Avdic, Andrew Lee, Tracy R. Ross, Karen C. Carroll2, and Trish M. Perl2
Author affiliations: Johns Hopkins University School of Medicine, Baltimore, Maryland, USA (L.L. Maragakis, A. Lee, K.C. Carroll, T.M. Perl); Johns Hopkins University Bloomberg School of Public Health, Baltimore (R. Chaiwarith); Centers for Disease Control and Prevention, Atlanta, Georgia, USA (A. Srinivasan); University of California, San Diego, California, USA (F.J. Torriani); The Johns Hopkins Hospital, Baltimore (E. Avdic, T.R. Ross)

Main Article

Table 2

Demographic and clinical characteristics of patients with Sphingomonas paucimobilis bloodstream infection, United States, 2007*

Patient no./ age, y/gender Hospital unit (US state) Clinical diagnosis Date(s) of fentanyl administration† Date(s) of infection Treatment Outcome PFGE strain‡
1/65/M Medicine (MD) Osteomyelitis; MRSA wound infection NA Nov 14 ADT, central line removed and replaced Survived Unique
2/64/M NCCU (MD) Subarachnoid hemorrhage Oct 29–31,
Nov 2–3,
Nov 11–22 Nov 14, Nov 18 ADT, central line removed and replaced Survived A
3/46/F NCCU (MD) Subarachnoid hemorrhage Nov 10–11
Nov 16–18 Nov 11
Nov 17
Nov 19 ADT, central line removed and replaced Survived A
4/69/F NCCU (MD) Subarachnoid hemorrhage Nov 18 Nov 18 ADT, central line removed and replaced Survived A
5/38/F MICU (MD) Group A streptococcal sepsis Nov 16 Nov 16 ADT§ Died A
6/38/M Oncology (MD) Head and neck tumor Nov 20,
Nov 26 Nov 20,
Nov 23 ADT, implanted medication port removed and replaced Survived A
7/38/M SICU (CA) Temporal lobe hemorrhage Oct 29 Oct 29 ADT Survived NA¶
8/59/M SICU (CA) Entero-cutaneous fistula; aorto-bifemoral bypass surgery Nov 8 Nov 8 ADT Survived NA¶

*All infections (except in patient 1) developed after administration of intravenous fentanyl compounded at an out-of-state pharmacy; MD, Maryland; CA, California; NCCU, neurologic critical care unit; MICU, medical intensive care unit; SICU, surgical intensive care unit; NA, not applicable; ADT, antimicrobial drug therapy; MRSA, methicillin-resistant Staphylococcus aureus; PFGE, pulsed-field gel electrophoresis.
†Intravenous fentanyl in 0.9% sodium chloride solution from a 250-mL (10 mcg/mL) bag prepared at compounding pharmacy A.
‡Strain A is the outbreak strain that was indistinguishable by PFGE from the fentanyl isolates.
§The patient died of Group A streptococcal sepsis before the blood culture results for S. paucimobilis became available.
¶Isolates from patients 7 and 8 in the California hospital were not available for strain typing.

Main Article

1Data presented in part at the 18th Annual Meeting of the Society for Healthcare Epidemiology of America; Orlando, Florida; April 6, 2008 (abstract 478).

Page created: September 24, 2012
Page updated: September 24, 2012
Page reviewed: September 24, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.